NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda

by July 29, 2025
written by July 29, 2025

The Senate confirmed President Donald Trump’s pick to lead the Centers for Disease Control and Prevention after his first choice struggled to gain support.

Susan Monarez, a longtime fixture in Washington who has taken on leadership positions in a number of government public health roles, was confirmed by the Senate on Tuesday, crossing yet another position off the lengthy and growing number of nominees awaiting confirmation.

Monarez was confirmed on a 51to 47party line vote.

Across her roughly two-decade career in D.C., she has served as deputy director of the Advanced Research Projects Agency for Health within the Department of Health and Human Services and in roles at the White House, including at the Office of Science and Technology Policy and the National Security Council.

She is the first CDC director to undergo the Senate confirmation process after a new law changed the requirement in 2023. Prior to her confirmation, Monarez had served as the acting director of the CDC since the beginning of this year.

But Monarez, who has a Ph.D. in microbiology and immunology, was not Trump’s first pick to lead the public health agency, which is tasked with protecting Americans from public health threats.

Trump tapped Monarez in March shortly after withdrawing his nomination of Dr. David Weldon, a former House member, after it was clear that he couldn’t get enough votes from Senate Republicans to make it across the finish line.

He lauded Monarez’s credentials, and charged that Americans had ‘lost confidence’ in the CDC.

‘Dr. Monarez will work closely with our GREAT Secretary of Health and Human Services, Robert Kennedy Jr,’ he said on social media at the time. ‘Together, they will prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and, MAKE AMERICA HEALTHY AGAIN!’

But questions also linger on how well Monarez and Health and Human Services Secretary Robert F. Kennedy Jr. might work together.

During her confirmation hearing last month, Senate Democrats grilled Monarez over whether she agreed with Kennedy’s positions on vaccines. Kennedy has long been outspoken about his skepticism regarding vaccines, particularly COVID-19 vaccines.

The CDC has been hit with thousands of staff cuts and resignations and subject to changes in vaccine policy — notably Kennedy’s decision to remove the COVID-19 from the vaccine schedule for pregnant women and healthy children — in the last six months. 

‘I think vaccines save lives. I think that we need to continue to support the promotion of utilization of vaccines,’ Monarez said during her confirmation hearing.

Her confirmation also comes as Kennedy, in his budget request for the HHS, seeks a slash in funding to the CDC of nearly 50%, or from about $9.2 billion to $4.2 billion, for the upcoming fiscal year.

But Kennedy made clear in an X post at the time of her nomination that he supports Monarez to take on the position.

‘I handpicked Susan for this job because she is a longtime champion of MAHA values, and a caring, compassionate and brilliant microbiologist and a tech wizard who will reorient CDC toward public health and gold-standard science,’ he said. ‘I’m so grateful to President Trump for making this appointment.’

And an HHS spokesperson told Fox News Digital, ‘Once Dr. Monarez is confirmed, the Secretary looks forward to working with her to advance common-sense policies that will Make America Healthy Again.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Union Pacific to buy Norfolk in $85 billion mega U.S. railroad deal
next post
Trump pick Emil Bove confirmed as federal judge after furious Democrat walkout, whistleblower complaints

You may also like

Let liberals lose their minds over Sydney Sweeney...

July 31, 2025

Inside Biden confidante Steve Ricchetti’s ‘combative’ eight-hour grilling...

July 31, 2025

New tech-focused MAHA initiatives will usher in ‘new...

July 30, 2025

Bernie Sanders to force Senate vote on blocking...

July 30, 2025

SCOTUS to discuss Ghislaine Maxwell’s case privately in...

July 30, 2025

Top GOP senator demands probe into whether Jack...

July 30, 2025

Trump admin sanctions Brazilian judge overseeing Bolsonaro coup-plot...

July 30, 2025

Democratic lawmaker ‘no longer on speaking terms’ with...

July 30, 2025

Agent’s alleged attempt to smuggle wife on Trump’s...

July 30, 2025

Schumer says century-old law forces Trump DOJ, FBI...

July 30, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Oil and natural gas: Oil is back on the positive side

    • 2

      Gold and Silver: Gold remains stable in the $2420 zone

    • 3

      The dollar index continues to pull back to a new low

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

    Recent Posts

    • Let liberals lose their minds over Sydney Sweeney while I go jeans shopping

      July 31, 2025
    • Trump ends de minimis exemption for global low-cost goods

      July 31, 2025
    • Inside Biden confidante Steve Ricchetti’s ‘combative’ eight-hour grilling in House Oversight cover-up probe

      July 31, 2025
    • Recall warns some Celsius energy drink cans accidentally contain alcohol

      July 31, 2025
    • Bernie Sanders to force Senate vote on blocking arms sales to Israel

      July 30, 2025

    Categories

    • Economy (20)
    • Editor's Pick (404)
    • Investing (20)
    • Stock (43)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick